IL6 and COVID-19: COVID-19 disease severity was linked to multiple hematological markers (lymphopenia, thrombocytopenia, neutrophilia) and inflammatory markers (CRP, IL-6, ferritin) [13–18], providing a rationale for research on PTX in COVID-19, as it affects many of those markers [19–21].